Compare Strategy Inc. (MSTR) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Strategy Inc. vs Regeneron Pharmaceuticals Inc — how do they compare? Strategy Inc. trades at $101.74 (market cap $35.47B), while Regeneron Pharmaceuticals Inc trades at $673.67 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is the larger of the two by market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Strategy Inc. pays none. Which is the better fit depends on your goals.
| MSTR | REGN | |
|---|---|---|
Market Cap | $35.47B | $70.47B |
Sector | Technology | Health |
52-Week High | $426.40 | $812.27 |
52-Week Low | $82.31 | $545.46 |
Enterprise Value | $50.50B | $64.42B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
